Czechia vs Singapore: Treatment for hypertension, male
Czechia
59.1%
in 2019
Singapore
58.9%
in 2019
Czechia rank
9th
Singapore rank
10th
Treatment for hypertension, male over time
- Czechia
- Singapore
How they compare
Czechia currently reports 59.1% against 58.9% in Singapore, a difference of 0.2%.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Czechia ahead.
Czechia ranks 9th and Singapore ranks 10th of 192 countries.
Across the 3 decades both report, Czechia averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Czechia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 34.9% | 33.8% | 1.0% | Czechia |
| 2000s | 45.3% | 44.9% | 0.4% | Czechia |
| 2010s | 55.0% | 55.4% | 0.4% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Czechia or Singapore?
- Czechia, at 59.1% against 58.9% in Singapore as of 2019.
- What is the difference in treatment for hypertension, male between Czechia and Singapore?
- 0.2%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do Czechia and Singapore rank globally for treatment for hypertension, male?
- Czechia ranks 9th and Singapore ranks 10th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.